Regulon

Regulon: R-2982

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
83.1230117Pr-0Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
9168 ENSG00000034510 TMSB10 P63313
29957 ENSG00000085491 SLC25A24 Q6NUK1
3956 ENSG00000100097 LGALS1 P09382
3597 ENSG00000131724 IL13RA1 P78552
3601 ENSG00000134470 IL15RA K9N1J3
4060 ENSG00000139329 LUM P51884
5937 ENSG00000153250 RBMS1 P29558
302 ENSG00000182718 ANXA2 P07355

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
DAVANATLGALS3UnknownINHIBITORGalectin-1 inhibitor20
CINTREDEKIN BESUDOTOXIL4RProteinBINDING AGENTInterleukin 13 receptor binding agent33
RECOMBINANT HUMAN INTERLEUKIN-15IL2RBUnknownAGONISTInterleukin-15 receptor agonist20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2982

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-04794SLC6A3down-regulatesDR1activatesR-298284Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

DAVANAT, CINTREDEKIN BESUDOTOX, RECOMBINANT HUMAN INTERLEUKIN-15

CMF-05453KIAA1549up-regulatesDR1activatesR-298281Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

DAVANAT, CINTREDEKIN BESUDOTOX, RECOMBINANT HUMAN INTERLEUKIN-15

CMF-09202TANC2up-regulatesDR1activatesR-298282Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

DAVANAT, CINTREDEKIN BESUDOTOX, RECOMBINANT HUMAN INTERLEUKIN-15

CMF-12797HOXA6down-regulatesDR1activatesR-298283Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

DAVANAT, CINTREDEKIN BESUDOTOX, RECOMBINANT HUMAN INTERLEUKIN-15

CMF-19751BVESup-regulatesDR1activatesR-298284Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

DAVANAT, CINTREDEKIN BESUDOTOX, RECOMBINANT HUMAN INTERLEUKIN-15

CMF-21652MUC17up-regulatesDR1activatesR-298285Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

DAVANAT, CINTREDEKIN BESUDOTOX, RECOMBINANT HUMAN INTERLEUKIN-15

CMF-26962TMTC1down-regulatesDR1activatesR-298282Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

DAVANAT, CINTREDEKIN BESUDOTOX, RECOMBINANT HUMAN INTERLEUKIN-15